Table Of Contents
1. Market Context & Strategic Relevance
1.1 Opening Context (Why the market matters)
1.1.1 Why This Market Is Gaining Strategic Attention
1.1.2 Business Decisions This Report Supports
1.2 Scope
1.3 Research & Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Software Type
2.3.2 Market Size By Clinical Specialty
2.3.3 Market Size By End User
2.3.4 Market Size By Deployment Mode
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO's Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter's) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1. Data, Computing & Cloud Infrastructure Providers
3.4.2. AI Software Medical Device Developers
3.4.3. Imaging Platforms, Distributors & Channel Partners
3.4.4. End Users (Hospitals, Laboratories, Clinics & Home Care)
3.5 Industry Life Cycle Assessment
4. Statistical Insights & Trends Reporting
4.1 Algorithm Performance & Technology Metrics
4.1.1 Sensitivity & Specificity Benchmarks
4.1.2 Foundation Model & Multi-Finding Adoption
4.1.3 Generative AI Report Drafting Developments
4.1.4 Real-World Performance Monitoring
4.2 Regulatory & Clinical Validation Statistics
4.2.1 Number of AI-Enabled Device Authorizations by Region
4.2.2 Predetermined Change Control Plan Adoption
4.2.3 Breakthrough Designation Activity
4.2.4 Clinical Trials & Peer-Reviewed Evidence
4.3 Cost & Operational Efficiency
4.3.1 Average Subscription & Licensing Models
4.3.2 Reading Time & Turnaround Reductions
4.3.3 Integration & Implementation Cost
4.3.4 Reimbursement & Payment Developments
4.4 Adoption & Geographic Penetration
4.4.1 Share of Hospitals & Departments Using AI
4.4.2 Adoption Across Imaging Modalities
4.4.3 Home & Remote Monitoring Deployment
4.4.4 Distribution Across Major Regions
4.5 Innovation, Technology & Development Outcomes
4.5.1 Platform Marketplaces & Interoperability
4.5.2 Multimodal & Wearable Data Integration
4.5.3 Funding, Partnerships & Acquisition Activity
4.5.4 Cybersecurity, Bias & Governance Developments
5. AI-Enabled Software As A Medical Device Market Segmental Analysis, By Software Type
5.1 Introduction
5.2 Diagnostic
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022–2035
5.3 Therapeutic
5.4 Monitoring
5.5 Clinical Decision Support
5.6 Workflow and Administrative
6. AI-Enabled Software As A Medical Device Market Segmental Analysis, By Clinical Specialty
6.1 Introduction
6.2 Radiology and Imaging
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Cardiology
6.4 Neurology
6.5 Pathology
6.6 Ophthalmology
6.7 Oncology
6.8 Others
7. AI-Enabled Software As A Medical Device Market Segmental Analysis, By End User
7.1 Introduction
7.2 Hospitals
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Ambulatory Care Centers
7.4 Diagnostic Laboratories
7.5 Home Healthcare Settings
7.6 Specialty Clinics
8. AI-Enabled Software As A Medical Device Market Segmental Analysis, By Deployment Mode
8.1 Introduction
8.2 Cloud-Based
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022–2035
8.3 On-Premises
8.4 Hybrid
9. AI-Enabled Software As A Medical Device Market Segmental Analysis, By Region
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 AI-Enabled Software As A Medical Device Market Size & Forecast, By Software Type, 2022–2035
9.2.3 AI-Enabled Software As A Medical Device Market Size & Forecast, By Clinical Specialty, 2022–2035
9.2.4 AI-Enabled Software As A Medical Device Market Size & Forecast, By End User, 2022–2035
9.2.5 AI-Enabled Software As A Medical Device Market Size & Forecast, By Deployment Mode, 2022–2035
9.2.6 AI-Enabled Software As A Medical Device Market Size & Forecast, By Country, 2022–2035
9.2.6.1 US
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 AI-Enabled Software As A Medical Device Market Size & Forecast, By Software Type, 2022–2035
9.3.3 AI-Enabled Software As A Medical Device Market Size & Forecast, By Clinical Specialty, 2022–2035
9.3.4 AI-Enabled Software As A Medical Device Market Size & Forecast, By End User, 2022–2035
9.3.5 AI-Enabled Software As A Medical Device Market Size & Forecast, By Deployment Mode, 2022–2035
9.3.6 AI-Enabled Software As A Medical Device Market Size & Forecast, By Country, 2022–2035
9.3.6.1 Germany
9.3.6.2 France
9.3.6.3 UK
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Poland
9.3.6.7 Russia
9.3.6.8 Rest of Europe
9.4 Asia Pacific
9.4.1 Key Trends
9.4.2 AI-Enabled Software As A Medical Device Market Size & Forecast, By Software Type, 2022–2035
9.4.3 AI-Enabled Software As A Medical Device Market Size & Forecast, By Clinical Specialty, 2022–2035
9.4.4 AI-Enabled Software As A Medical Device Market Size & Forecast, By End User, 2022–2035
9.4.5 AI-Enabled Software As A Medical Device Market Size & Forecast, By Deployment Mode, 2022–2035
9.4.6 AI-Enabled Software As A Medical Device Market Size & Forecast, By Country, 2022–2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 AI-Enabled Software As A Medical Device Market Size & Forecast, By Software Type, 2022–2035
9.5.3 AI-Enabled Software As A Medical Device Market Size & Forecast, By Clinical Specialty, 2022–2035
9.5.4 AI-Enabled Software As A Medical Device Market Size & Forecast, By End User, 2022–2035
9.5.5 AI-Enabled Software As A Medical Device Market Size & Forecast, By Deployment Mode, 2022–2035
9.5.6 AI-Enabled Software As A Medical Device Market Size & Forecast, By Country, 2022–2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 AI-Enabled Software As A Medical Device Market Size & Forecast, By Software Type, 2022–2035
9.6.3 AI-Enabled Software As A Medical Device Market Size & Forecast, By Clinical Specialty, 2022–2035
9.6.4 AI-Enabled Software As A Medical Device Market Size & Forecast, By End User, 2022–2035
9.6.5 AI-Enabled Software As A Medical Device Market Size & Forecast, By Deployment Mode, 2022–2035
9.6.6 AI-Enabled Software As A Medical Device Market Size & Forecast, By Country, 2022–2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 South Africa
9.6.6.5 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Year-Wise Strategies & Development, 2022–2026
10.3 Market Share Analysis, 2025
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Aidoc Medical Ltd.
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 Geographical Presence
10.6.1.5 SWOT Analysis
10.6.2 Viz.ai, Inc.
10.6.3 Qure.ai Technologies Private Limited
10.6.4 Lunit Inc.
10.6.5 RapidAI
10.6.6 Heartflow, Inc.
10.6.7 Cleerly, Inc.
10.6.8 Brainomix Limited
10.6.9 Eyenuk, Inc.
10.6.10 Digital Diagnostics Inc.
10.6.11 Tempus AI, Inc.
10.6.12 Ultromics Ltd.
10.6.13 Us2.ai
10.6.14 Harrison.ai
10.6.15 RadNet, Inc.
10.6.16 Sectra AB
10.6.17 Eko Health, Inc.
10.6.18 AliveCor, Inc.
10.6.19 Koninklijke Philips N.V.
10.6.20 iRhythm Holdings, Inc.
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Frequently Asked Questions
The market includes Aidoc, Viz.ai, Qure.ai, Lunit, RapidAI, Heartflow, Cleerly, Brainomix, Eyenuk, Digital Diagnostics, Tempus AI, Ultromics, Us2.ai, Harrison.ai, RadNet, Sectra, Eko Health, AliveCor, Philips and iRhythm, among others. These companies compete on the number of cleared indications, clinical evidence and workflow integration.
The main opportunities lie in generative artificial intelligence for report drafting, new cardiology, pathology and ophthalmology indications, and home-based monitoring. Hybrid deployment and platform marketplaces add further potential.
The key growth factor is the gap between clinical workload and workforce supply, together with a steady flow of regulatory clearances that widen the range of usable algorithms.
By software type, the Diagnostic segment dominated the market with approximately 39.28% share in 2025, supported by the early clearance and clear clinical value of detection and triage algorithms.
North America dominated the market with approximately 40.73% share in 2025, supported by regulatory maturity and early health system adoption. Asia Pacific is the fastest-growing region with a projected CAGR of 24.26% from 2026 to 2035.